Unilever Plc
—- Market cap
- —
- Debt
- —
- Cash
- −$4.40B
USD conversion input: 1 EUR = 1.116500 USD. FX date unavailable.
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: UL stock price vs BDX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BDX's multiple
Needs BDX P/E.
Implied fair value · at UL's multiple
Needs UL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
USD conversion input: 1 EUR = 1.116500 USD. FX date unavailable.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
UNILEVER PLC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
BECTON, DICKINSON AND COMPANY · implied price per share
Bear
$42.31
Base
$61.15
Bull
$85.69
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe UL can re-accelerate growth while sustaining its strong gross and net margins, then UL looks attractive versus BDX on P/E because the earnings multiple gap is large; if not, the current price looks less compelling given weak growth, leverage, and the DCF range below spot.
UL trades at 12.8x P/E versus BDX at 28.5x, which explains the large implied upside from the comparison model. However, the discount is not uniform across all valuation measures because UL is more expensive on EV/EBITDA and EV/Revenue, suggesting the market is not simply mispricing UL on every basis.
Supporting Metrics